These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 8495243)

  • 1. The diuretic action of 8-cyclopentyl-1,3-dipropylxanthine, a selective A1 adenosine receptor antagonist.
    Knight RJ; Bowmer CJ; Yates MS
    Br J Pharmacol; 1993 May; 109(1):271-7. PubMed ID: 8495243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal tubular site of action of KW-3902, a novel adenosine A1-receptor antagonist, in anesthetized rats.
    Mizumoto H; Karasawa A
    Jpn J Pharmacol; 1993 Mar; 61(3):251-3. PubMed ID: 8483302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diuretic and renal protective effects of 8-(noradamantan-3-yl)-1,3-dipropylxanthine (KW-3902), a novel adenosine A1-receptor antagonist, via pertussis toxin insensitive mechanism.
    Mizumoto H; Karasawa A; Kubo K
    J Pharmacol Exp Ther; 1993 Jul; 266(1):200-6. PubMed ID: 8331558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amelioration of cisplatin-induced acute renal failure with 8-cyclopentyl-1,3-dipropylxanthine.
    Knight RJ; Collis MG; Yates MS; Bowmer CJ
    Br J Pharmacol; 1991 Dec; 104(4):1062-8. PubMed ID: 1810593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the selective A1 adenosine antagonist 8-cyclopentyl-1,3-dipropylxanthine on acute renal dysfunction induced by Escherichia coli endotoxin in rats.
    Knight RJ; Bowmer CJ; Yates MS
    J Pharm Pharmacol; 1993 Nov; 45(11):979-84. PubMed ID: 7908041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of adenosine on water and sodium excretion.
    Yagil Y
    J Pharmacol Exp Ther; 1994 Feb; 268(2):826-35. PubMed ID: 8113995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of adenosine A1-agonist and -antagonist on urinary volume and Na excretion in IAP-treated and non-treated rats.
    Mizumoto H; Karasawa A
    Jpn J Pharmacol; 1993 Oct; 63(2):257-9. PubMed ID: 8283837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diuretic effects of KW-3902, a novel adenosine A1-receptor antagonist, in anesthetized dogs.
    Yamagata T; Kobayashi T; Kusaka H; Karasawa A
    Biol Pharm Bull; 1994 Dec; 17(12):1599-603. PubMed ID: 7735202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Segmental regulation of sodium and water excretion by TRPV1 activation in the kidney.
    Zhu Y; Wang DH
    J Cardiovasc Pharmacol; 2008 May; 51(5):437-42. PubMed ID: 18398380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natriuretic and diuretic actions of a highly selective adenosine A1 receptor antagonist.
    Wilcox CS; Welch WJ; Schreiner GF; Belardinelli L
    J Am Soc Nephrol; 1999 Apr; 10(4):714-20. PubMed ID: 10203354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amelioration of glycerol-induced acute renal failure in the rat with 8-cyclopentyl-1,3-dipropylxanthine.
    Kellett R; Bowmer CJ; Collis MG; Yates MS
    Br J Pharmacol; 1989 Nov; 98(3):1066-74. PubMed ID: 2590769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An orally active adenosine A1 receptor antagonist, FK838, increases renal excretion and maintains glomerular filtration rate in furosemide-resistant rats.
    Schnackenberg CG; Merz E; Brooks DP
    Br J Pharmacol; 2003 Aug; 139(8):1383-8. PubMed ID: 12922924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of 8-cyclopentyl-1,3-dipropylxanthine on the development of cyclosporin-induced acute renal failure.
    Panjehshahin MR; Chahil RS; Collis MG; Bowmer CJ; Yates MS
    J Pharm Pharmacol; 1991 Jul; 43(7):525-8. PubMed ID: 1682472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the adenosine A1 receptor inhibitor FK 838 on proximal tubular fluid output in rats.
    Bak M; Thomsen K
    Nephrol Dial Transplant; 2004 May; 19(5):1077-82. PubMed ID: 14993484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diuretic effect induced by intrarenal infusion of nisoldipine in anaesthetized dogs.
    Kageyama M; Matsumura Y; Hayashi K; Hosokawa T; Morimoto S
    Clin Exp Pharmacol Physiol; 1989 Sep; 16(9):719-24. PubMed ID: 2805435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined effects of carbonic anhydrase inhibitor and adenosine A1 receptor antagonist on hemodynamic and tubular function in the kidney.
    Miracle CM; Rieg T; Blantz RC; Vallon V; Thomson SC
    Kidney Blood Press Res; 2007; 30(6):388-99. PubMed ID: 17890869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of KW-3902 (8-(noradamantan-3-yl)-1,3-dipropylxanthine), an adenosine A1-receptor antagonist, on urinary excretions of various electrolytes in rats.
    Nagashima K; Karasawa A
    Biol Pharm Bull; 1996 Jul; 19(7):940-3. PubMed ID: 8839965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CVT-124, a novel adenosine A1 receptor antagonist with unique diuretic activity.
    Gellai M; Schreiner GF; Ruffolo RR; Fletcher T; DeWolf R; Brooks DP
    J Pharmacol Exp Ther; 1998 Sep; 286(3):1191-6. PubMed ID: 9732378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natriuretic and hypotensive effect of adenosine-1 blockade in essential hypertension.
    van Buren M; Bijlsma JA; Boer P; van Rijn HJ; Koomans HA
    Hypertension; 1993 Nov; 22(5):728-34. PubMed ID: 8225532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diuretic and saliuretic effects of 1,3-dipropyl-8-cyclopentylxanthine, a selective A1-adenosine receptor antagonist.
    Collis MG; Shaw G; Keddie JR
    J Pharm Pharmacol; 1991 Feb; 43(2):138-9. PubMed ID: 1672902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.